Discontinuing trimetazidine treatment in people with Parkinson’s disease…
Vanessa Pataia
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Vanessa Pataia
Kynmobi (apomorphine hydrochloride) soluble film has been approved by Health Canada…
A miniature, wireless, and magnetically powered neural stimulator may be the future of deep brain stimulation for…
A generic version of the transdermal (absorbed through the skin) Neupro patch (…
Two compounds with hormone-like effects — prostaglandin E1 (PGE1) and prostaglandin A1 (PGA1) — may help to increase…
Aptinyx has paused patient enrollment in its Phase 2 trial evaluating NYX-458…
Investigational therapy ANVS401 (also known as Posiphen) reversed gastrointestinal dysfunction linked to early Parkinson’s in two mouse models of…